| 名稱 | CYP2D6*2 Reference Standard |
| 型號 | CBPA0045 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | CYP2D6*2 Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- CYP2C9基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- VKORC1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- MTHFR基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2D6基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2C19基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 腫瘤細(xì)胞內(nèi)的膠原蛋白有哪些作用？
- 北京細(xì)胞庫關(guān)于細(xì)胞存儲(chǔ)的意義了解下
- 5T4 (TPBG) 藥靶篩選模型
- *針對肝癌的PD-1抗體獲FDA批準(zhǔn)，國產(chǎn)PD-1抗體進(jìn)入三期
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 用藥指導(dǎo) > CBPA0045CYP2D6*2 Reference Standard
- 詳細(xì)內(nèi)容
| CBPA0045 | |
| Format | Genomic DNA |
| Description | CYP2D6, cytochrome P450 family 2 subfamily D member 6, is a member of the cytochrome P450 family of monooxygenases that catalyzes drug metabolism (PMID: 28480783). CYP2D6 variants have been associated with risks of various cancers (PMID: 22994728, PMID: 16550168) and may alter the metabolism of tamoxifen in breast cancer patients. |
| Technical Data | |
| Gene | CYP2D6*2 |
| Mutation Type 1 | AA Change: p.R296C |
| DNA Change: NM_000106.6:c.886C>T | |
| Chr position (GRCh38): NC_000022.11:g.42127941G>A | |
| Mutation Type 2 | AA Change: p.S486T |
| DNA Change: NM_000106.6:c.1457G>C | |
| Chr position (GRCh38):NC_000022.11:g.42126611C>G | |
| Allelic Frequency | 50% |
| Zygosity | Heterozygous |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
Figure 1. CYP2D6*2 Reference Standard p.R296C
Figure 2. CYP2D6*2 Reference Standard p.S486T |
| Storage | 4°C |
| Expiry | 36 months from the date of manufacture |
員_a.png)